Susvimo

Genentech, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 15, 2025
Approval ID: 9c6d9e2a-9a77-4d11-b692-de87cfde3444
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.